Clinical Trials on Neonatal COVID-19 Disease in Brazil
Total 327 results
-
AstraZenecaCompletedCOVID-19United States, Spain, United Kingdom, Brazil, Germany, Ukraine, Japan, Italy, Poland, Russian Federation, Mexico, Czechia, Argentina, Hungary, Peru
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 Infection | Maternal ImmunizationUnited States, United Kingdom, Spain, Brazil, South Africa
-
CanSino Biologics Inc.Beijing Institute of BiotechnologyCompletedCOVID-19Mexico, Argentina, Chile, Pakistan, Russian Federation
-
Matthew Neal MDNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingCovid19United States, Spain, Brazil, Italy
-
Ictal GroupUnknownCOVID-19 | Critically Ill | EncephalopathyEgypt, France, United States, Brazil, Colombia, Mexico, Spain
-
PfizerCompletedCOVID-19Spain, United States, Australia, Canada, Bulgaria, Slovakia, Mexico, Hungary, Brazil
-
Daniel BenjaminNational Center for Advancing Translational Sciences (NCATS); Biomedical Advanced...CompletedCovid19United States, Brazil, Argentina, Mexico, Peru
-
MedicagoActive, not recruitingSARS-CoV-2 InfectionUnited States, Canada, United Kingdom, Argentina, Brazil, Mexico
-
University of Sao Paulo General HospitalUnity Health Toronto; University of Vermont Medical CenterCompletedSevere Acute Respiratory Syndrome | Coronavirus Infection | COVID | Anticoagulants and Bleeding Disorders | Thromboembolism, VenousBrazil
-
PfizerCompletedCOVID-19United States, Russian Federation, Thailand, Czechia, Colombia, Bulgaria, Japan, South Africa, Turkey, Argentina, Hungary, Malaysia, Mexico, Poland, Spain, Ukraine, Brazil
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Germany, Turkey, South Africa, Argentina, Brazil
-
PfizerTerminatedCOVID-19United States, Malaysia, Thailand, Turkey, Spain, Czechia, Poland, Bulgaria, Japan, Korea, Republic of, South Africa, Hungary, Argentina, Brazil, Colombia, Mexico, Puerto Rico, Romania, Slovakia, Ukraine
-
Population Health Research InstituteBayerCompletedSevere Acute Respiratory Syndrome | CoronavirusEgypt, Canada, Brazil, Colombia, Ecuador, India, Nepal, Pakistan, Philippines, Russian Federation, South Africa, United Arab Emirates
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Brazil, South Africa, Germany, Canada, Israel
-
Saint Luke's Health SystemAstraZeneca; George Clinical Pty Ltd; Saint Luke's Hospital of Kansas CityCompletedCOVID-19United States, Brazil, Argentina, India, Canada, Mexico, United Kingdom
-
PfizerCompletedCOVID-19United States, Korea, Republic of, Russian Federation, Czechia, Turkey, Malaysia, South Africa, Bulgaria, Poland, Hungary, Argentina, Brazil, Colombia, Japan, Mexico, Puerto Rico, Spain, Thailand, Ukraine, India
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; AIDS Clinical Trials... and other collaboratorsCompletedCovid19 | CoronavirusUnited States, Argentina, Brazil, Guatemala, Mexico, Philippines, Puerto Rico, South Africa, Canada
-
GlaxoSmithKlineCompletedSevere Acute Respiratory SyndromeUnited States, Russian Federation, Peru, Netherlands, Spain, South Africa, United Kingdom, Argentina, Brazil, France, Canada, Mexico, Poland, Belgium, India, Japan, Chile, Colombia, Italy
-
Grifols Therapeutics LLCTerminatedCOVID-19United States, Brazil, Chile, Colombia, Mexico
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)CompletedA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
Regeneron PharmaceuticalsCompletedCOVID-19United States, Mexico, Romania, Brazil, Chile, Moldova, Republic of
-
Kirby InstituteViiV Healthcare; University of Witwatersrand, South Africa; University of Liverpool and other collaboratorsCompletedCoronavirus Infection | HIV-infection/AidsUganda, Cameroon, Argentina, Brazil, India, Malaysia, Nigeria, South Africa, Thailand, Zimbabwe
-
Rigel PharmaceuticalsCompletedPneumonia, Viral | Pneumonia | Covid19 | SARS (Severe Acute Respiratory Syndrome) | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | SARS PneumoniaUnited States, Argentina, Brazil, Mexico
-
Synairgen Research Ltd.CompletedCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2United Kingdom, Italy, United States, Portugal, Israel, Germany, Belgium, India, Spain, Netherlands, Argentina, Brazil, Colombia, France, Mexico, Romania, Serbia
-
BioNTech SEPfizerRecruitingCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 VirusUnited States, South Africa, Brazil, Puerto Rico
-
BiotestRecruitingCOVID-19 | Pneumonia | Acute Respiratory Distress Syndrome | Community-acquired Pneumonia | Respiratory Infection | Bacterial Pneumonia | Viral Pneumonia | Fungal PneumoniaBelgium, Brazil, Latvia, Germany, Lithuania, South Africa, Argentina, Austria, France, Hungary, Slovakia, Turkey, Portugal, Spain